Mainz Biomed B.V. (MYNZ) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Mainz Biomed B.V.

NASDAQ: MYNZ · Real-Time Price · USD
1.73
0.09 (5.49%)
At close: Oct 03, 2025, 3:59 PM
1.67
-3.76%
After-hours: Oct 03, 2025, 07:46 PM EDT

Mainz Biomed B.V. Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.19 -28.66 -152 -256.36
PEG Ratio
-0.00 2.14 -12.69 -0.08
PS Ratio
4.68 841.61 7.59K 5.19K
PB Ratio
0.69 231.95 285.24 471.12
P/FCF Ratio
-0.24 -31.62 -260.61 -925.8
P/OCF Ratio
-0.24 -34.35 -272.23 -930.6
OCF/S Ratio
-19.12 -24.5 -27.87 -5.58
Debt / Equity Ratio
0.54 2.28 0.23 0.41
Quick Ratio
1.26 0.91 4.29 7.11
Current Ratio
1.32 0.97 4.33 7.11
Asset Turnover
0.07 0.06 0.03 0.06
Interest Coverage
-17.39 -32.91 -91.4 -28.67
Return on Equity
-3.58 -8.09 -1.88 -1.84
Return on Assets
-1.64 -1.71 -1.31 -1.16
Return on Invested Capital
-1.93 -2.34 -1.53 -1.12
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.64 0.57 0.34 0.31
Net Profit Margin
-24.22 -29.36 -49.92 -20.25
Pretax Profit Margin
-24.22 -29.36 -49.8 -20.26
Operating Profit Margin
-20.91 -29.75 -49.91 -16.84
FCF Margin
-19.4 -26.62 -29.12 -5.61
EBITDA Margin
-21.88 -27.93 -48.54 -19.54